Publicaciones en colaboración con investigadoras/es de Hospital Sierrallana (9)

2021

  1. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278

  2. Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1257-1268

2020

  1. A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262

  2. ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage

    Journal of Neurology, Vol. 267, Núm. 5, pp. 1291-1299

  3. Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis

    Neural Regeneration Research, Vol. 15, Núm. 11, pp. 2043-2044

2019

  1. Amyotrophic lateral sclerosis: A complex syndrome that needs an integrated research approach

    Neural Regeneration Research, Vol. 14, Núm. 2, pp. 193-196

2018

  1. Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis

    Journal of the Neurological Sciences

  2. Retinoids and amyotrophic lateral sclerosis

    JAMA Neurology

  3. The increasing importance of environmental conditions in amyotrophic lateral sclerosis

    International Journal of Biometeorology, Vol. 62, Núm. 8, pp. 1361-1374